Voloridge Investment Management LLC boosted its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 306.8% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 376,055 shares of the health services provider's stock after buying an additional 283,608 shares during the quarter. Voloridge Investment Management LLC owned approximately 0.66% of Maximus worth $28,073,000 as of its most recent SEC filing.
Other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in Maximus by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock valued at $488,829,000 after acquiring an additional 205,564 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Maximus by 14.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,406,592 shares of the health services provider's stock valued at $105,001,000 after purchasing an additional 177,075 shares during the last quarter. Van Berkom & Associates Inc. grew its holdings in Maximus by 8.5% during the fourth quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider's stock valued at $93,792,000 after purchasing an additional 98,264 shares during the period. Fuller & Thaler Asset Management Inc. grew its holdings in Maximus by 7.4% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 1,234,933 shares of the health services provider's stock valued at $92,188,000 after purchasing an additional 84,835 shares during the period. Finally, Janus Henderson Group PLC increased its position in Maximus by 2.0% in the fourth quarter. Janus Henderson Group PLC now owns 1,186,150 shares of the health services provider's stock worth $88,546,000 after buying an additional 22,711 shares during the last quarter. Institutional investors own 97.21% of the company's stock.
Analyst Ratings Changes
Separately, Wall Street Zen cut Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.
View Our Latest Stock Report on Maximus
Insider Buying and Selling
In related news, Director Jan Madsen sold 2,439 shares of the company's stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the sale, the director now owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. This represents a 11.88% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 1.60% of the stock is currently owned by insiders.
Maximus Stock Performance
NYSE MMS traded up $1.93 during trading on Tuesday, hitting $74.33. 73,749 shares of the company's stock traded hands, compared to its average volume of 560,569. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The stock has a market capitalization of $4.19 billion, a price-to-earnings ratio of 15.99 and a beta of 0.61. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $93.97. The business has a 50 day moving average of $69.44 and a 200-day moving average of $71.91.
Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, beating analysts' consensus estimates of $1.37 by $0.64. Maximus had a net margin of 5.28% and a return on equity of 21.95%. The company had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.29 billion. During the same period in the prior year, the company posted $1.57 EPS. Maximus's revenue was up 1.0% compared to the same quarter last year. As a group, equities research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.
Maximus Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.61%. Maximus's dividend payout ratio (DPR) is 23.86%.
About Maximus
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Articles
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
